Nestin expression correlates with nerve and retroperitoneal tissue invasion in pancreatic cancer

Masao Kawamoto, Toshiyuki Ishiwata, Kazumitsu Cho, Eiji Uchida, Murray Korc, Zenya Naito, Takashi Tajiri

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

Nestin was first described as an intermediate filament protein expressed in neuroepithelial stem cells. Nestin expression has also been reported in brain tumors, schwannomas, gastrointestinal stromal tumors, and melanomas. In the pancreas, Nestin expression has been detected in exocrine and mesenchymal cells, including stellate cells, pericytes, and endothelial cells. In the present study, we examined Nestin expression in human pancreatic ductal adenocarcinoma and sought to determine its role in this malignancy. Reverse transcription-polymerase chain reaction analysis demonstrated the presence of Nestin mRNA in all 10 tested pancreatic cancer cell lines, and quantitative reverse transcription-polymerase chain reaction revealed that Nestin mRNA levels were highest in PANC-1 cells and lowest in PK-8 cells. Immunofluorescent analysis revealed that Nestin localized in the outer cytoplasm of PANC-1 cells. Nestin immunoreactivity was present in the cancer cells in 20 (33.3%) of 60 cancer cases, and its expression was confirmed by in situ hybridization. Nestin expression was also increased in peripheral nerve fibers adjacent to cancer cells and in peripheral nerve fibers invaded by cancer cells. Clinicopathologically, there was a statistically significant association between Nestin expression in pancreatic cancer cells and nerve invasion (P = .010) and the presence of cancer cells in the tumor resection margins (P = .003). Nestin-positive cases exhibited similar survival after resection by comparison with Nestin-negative cases, irrespective of whether they were given adjuvant therapy. These findings indicate that Nestin expression in pancreatic cancer cells may contribute to nerve and stromal invasion in this malignancy.

Original languageEnglish (US)
Pages (from-to)189-198
Number of pages10
JournalHuman Pathology
Volume40
Issue number2
DOIs
StatePublished - Feb 2009
Externally publishedYes

Fingerprint

Nerve Tissue
Nestin
Pancreatic Neoplasms
Neoplasms
Peripheral Nerves
Nerve Fibers
Reverse Transcription
Neuroepithelial Cells
Intermediate Filament Proteins
Polymerase Chain Reaction
Pericytes
Messenger RNA
Gastrointestinal Stromal Tumors
Neurilemmoma
Brain Neoplasms
In Situ Hybridization
Pancreas
Melanoma

Keywords

  • Immunohistochemistry
  • Nerve fiber
  • Nestin
  • Pancreatic cancer
  • RT-PCR

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Kawamoto, M., Ishiwata, T., Cho, K., Uchida, E., Korc, M., Naito, Z., & Tajiri, T. (2009). Nestin expression correlates with nerve and retroperitoneal tissue invasion in pancreatic cancer. Human Pathology, 40(2), 189-198. https://doi.org/10.1016/j.humpath.2008.02.022

Nestin expression correlates with nerve and retroperitoneal tissue invasion in pancreatic cancer. / Kawamoto, Masao; Ishiwata, Toshiyuki; Cho, Kazumitsu; Uchida, Eiji; Korc, Murray; Naito, Zenya; Tajiri, Takashi.

In: Human Pathology, Vol. 40, No. 2, 02.2009, p. 189-198.

Research output: Contribution to journalArticle

Kawamoto, M, Ishiwata, T, Cho, K, Uchida, E, Korc, M, Naito, Z & Tajiri, T 2009, 'Nestin expression correlates with nerve and retroperitoneal tissue invasion in pancreatic cancer', Human Pathology, vol. 40, no. 2, pp. 189-198. https://doi.org/10.1016/j.humpath.2008.02.022
Kawamoto, Masao ; Ishiwata, Toshiyuki ; Cho, Kazumitsu ; Uchida, Eiji ; Korc, Murray ; Naito, Zenya ; Tajiri, Takashi. / Nestin expression correlates with nerve and retroperitoneal tissue invasion in pancreatic cancer. In: Human Pathology. 2009 ; Vol. 40, No. 2. pp. 189-198.
@article{2ccbb15ed5134dfdbc8340eb069ff079,
title = "Nestin expression correlates with nerve and retroperitoneal tissue invasion in pancreatic cancer",
abstract = "Nestin was first described as an intermediate filament protein expressed in neuroepithelial stem cells. Nestin expression has also been reported in brain tumors, schwannomas, gastrointestinal stromal tumors, and melanomas. In the pancreas, Nestin expression has been detected in exocrine and mesenchymal cells, including stellate cells, pericytes, and endothelial cells. In the present study, we examined Nestin expression in human pancreatic ductal adenocarcinoma and sought to determine its role in this malignancy. Reverse transcription-polymerase chain reaction analysis demonstrated the presence of Nestin mRNA in all 10 tested pancreatic cancer cell lines, and quantitative reverse transcription-polymerase chain reaction revealed that Nestin mRNA levels were highest in PANC-1 cells and lowest in PK-8 cells. Immunofluorescent analysis revealed that Nestin localized in the outer cytoplasm of PANC-1 cells. Nestin immunoreactivity was present in the cancer cells in 20 (33.3{\%}) of 60 cancer cases, and its expression was confirmed by in situ hybridization. Nestin expression was also increased in peripheral nerve fibers adjacent to cancer cells and in peripheral nerve fibers invaded by cancer cells. Clinicopathologically, there was a statistically significant association between Nestin expression in pancreatic cancer cells and nerve invasion (P = .010) and the presence of cancer cells in the tumor resection margins (P = .003). Nestin-positive cases exhibited similar survival after resection by comparison with Nestin-negative cases, irrespective of whether they were given adjuvant therapy. These findings indicate that Nestin expression in pancreatic cancer cells may contribute to nerve and stromal invasion in this malignancy.",
keywords = "Immunohistochemistry, Nerve fiber, Nestin, Pancreatic cancer, RT-PCR",
author = "Masao Kawamoto and Toshiyuki Ishiwata and Kazumitsu Cho and Eiji Uchida and Murray Korc and Zenya Naito and Takashi Tajiri",
year = "2009",
month = "2",
doi = "10.1016/j.humpath.2008.02.022",
language = "English (US)",
volume = "40",
pages = "189--198",
journal = "Human Pathology",
issn = "0046-8177",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Nestin expression correlates with nerve and retroperitoneal tissue invasion in pancreatic cancer

AU - Kawamoto, Masao

AU - Ishiwata, Toshiyuki

AU - Cho, Kazumitsu

AU - Uchida, Eiji

AU - Korc, Murray

AU - Naito, Zenya

AU - Tajiri, Takashi

PY - 2009/2

Y1 - 2009/2

N2 - Nestin was first described as an intermediate filament protein expressed in neuroepithelial stem cells. Nestin expression has also been reported in brain tumors, schwannomas, gastrointestinal stromal tumors, and melanomas. In the pancreas, Nestin expression has been detected in exocrine and mesenchymal cells, including stellate cells, pericytes, and endothelial cells. In the present study, we examined Nestin expression in human pancreatic ductal adenocarcinoma and sought to determine its role in this malignancy. Reverse transcription-polymerase chain reaction analysis demonstrated the presence of Nestin mRNA in all 10 tested pancreatic cancer cell lines, and quantitative reverse transcription-polymerase chain reaction revealed that Nestin mRNA levels were highest in PANC-1 cells and lowest in PK-8 cells. Immunofluorescent analysis revealed that Nestin localized in the outer cytoplasm of PANC-1 cells. Nestin immunoreactivity was present in the cancer cells in 20 (33.3%) of 60 cancer cases, and its expression was confirmed by in situ hybridization. Nestin expression was also increased in peripheral nerve fibers adjacent to cancer cells and in peripheral nerve fibers invaded by cancer cells. Clinicopathologically, there was a statistically significant association between Nestin expression in pancreatic cancer cells and nerve invasion (P = .010) and the presence of cancer cells in the tumor resection margins (P = .003). Nestin-positive cases exhibited similar survival after resection by comparison with Nestin-negative cases, irrespective of whether they were given adjuvant therapy. These findings indicate that Nestin expression in pancreatic cancer cells may contribute to nerve and stromal invasion in this malignancy.

AB - Nestin was first described as an intermediate filament protein expressed in neuroepithelial stem cells. Nestin expression has also been reported in brain tumors, schwannomas, gastrointestinal stromal tumors, and melanomas. In the pancreas, Nestin expression has been detected in exocrine and mesenchymal cells, including stellate cells, pericytes, and endothelial cells. In the present study, we examined Nestin expression in human pancreatic ductal adenocarcinoma and sought to determine its role in this malignancy. Reverse transcription-polymerase chain reaction analysis demonstrated the presence of Nestin mRNA in all 10 tested pancreatic cancer cell lines, and quantitative reverse transcription-polymerase chain reaction revealed that Nestin mRNA levels were highest in PANC-1 cells and lowest in PK-8 cells. Immunofluorescent analysis revealed that Nestin localized in the outer cytoplasm of PANC-1 cells. Nestin immunoreactivity was present in the cancer cells in 20 (33.3%) of 60 cancer cases, and its expression was confirmed by in situ hybridization. Nestin expression was also increased in peripheral nerve fibers adjacent to cancer cells and in peripheral nerve fibers invaded by cancer cells. Clinicopathologically, there was a statistically significant association between Nestin expression in pancreatic cancer cells and nerve invasion (P = .010) and the presence of cancer cells in the tumor resection margins (P = .003). Nestin-positive cases exhibited similar survival after resection by comparison with Nestin-negative cases, irrespective of whether they were given adjuvant therapy. These findings indicate that Nestin expression in pancreatic cancer cells may contribute to nerve and stromal invasion in this malignancy.

KW - Immunohistochemistry

KW - Nerve fiber

KW - Nestin

KW - Pancreatic cancer

KW - RT-PCR

UR - http://www.scopus.com/inward/record.url?scp=58149123808&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58149123808&partnerID=8YFLogxK

U2 - 10.1016/j.humpath.2008.02.022

DO - 10.1016/j.humpath.2008.02.022

M3 - Article

VL - 40

SP - 189

EP - 198

JO - Human Pathology

JF - Human Pathology

SN - 0046-8177

IS - 2

ER -